A comprehensive review of chemical activators and inhibitors used in cell biology research.
Cell biology is the study of cell structure, physiological properties and cell function. It involves the study of cell organelles, interactions between the cells and their environment, life cycle, division, and death. Cell biology is closely related to genetics, molecular biology, developmental biology, and biochemistry.

Inhibitors and activators are critical tools for researchers in the field of cell biology to obtain a comprehensive understanding of cell function, cell signaling and the intracellular mechanisms that control cell fate, function, and phenotype. Here we review commonly used inhibitors and activators for studying various aspects of cell biology for eukaryotic cells like secretion, adhesion, cytoskeletal dynamics, endoplasmic reticulum and Golgi. Another Labome article addresses endocytosis and its activators and inhibitors. Researchers have raised and discussed quality and specificity concern about small molecule inhibitors and activators [1], similar to the issues about antibody quality.
The cytoskeleton provides any cell with structure and shape. Eukaryotic cells contain three main kinds of cytoskeletal filaments: microfilaments, intermediate filaments, and microtubules. Commonly used inhibitors of cell cytoskeleton are listed in Table 1 and commonly used activators of cell cytoskeleton are listed in Table 2.
These are the thinnest filaments of the cytoskeleton. They are composed of linear polymers of actin subunits, and generate force by elongation at one end of the filament coupled with shrinkage at the other, causing a net movement of the intervening strand.
The average size of these filaments is 10 nanometers in diameter and are more stable (strongly bound) than actin filaments, and heterogeneous constituents of the cytoskeleton. Intermediate filaments organize the internal 3-dimensional structure of the cell, organelles and serving as structural components of the nuclear lamina. They also participate in some cell-cell and cell-matrix junctions.
They are hollow cylinders about 23 nm in diameter, most commonly comprising 13 protofilaments which, in turn, are polymers of alpha and beta tubulin. They have a very dynamic behavior, binding GTP for polymerization, and are commonly organized by the centrosome.
Inhibitor | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Cytochalasin B (C29H37NO5) / D (C30H37NO6) | Actin | Binds to growing ends of actin nuclei and F-actin, inhibiting polymerization. Induces depolymerization of actin. | Soluble in DMSO and ethanol. Inhibits contractility. Causes cell cycle arrest at the G1-S transition. |
Latrunculin A (C22H31NO5S) | Actin | Disrupts microfilament-mediated processes. Forms a 1:1 complex with monomeric G-actin (Kd = 200 nM). | Soluble in DMSO and ethanol. Inhibits 10- to 100-fold more potently than cytochalasins. Inhibits phagocytosis by macrophages. It is more potent than Lantraculin B. |
Latrunculin B (C20H29NO5S) | Actin | Inhibits actin polymerization in-vitro (Kd = 60 nM). Disrupts microfilament organization as well as microfilament-mediated processes. | Soluble in DMSO, MeOH, or EtOH. Inhibits 10 to 100-fold more potently than cytochalasins. Slowly inactivated by serum leading to transient induced changes in the continued presence of the compound. |
Wiskostatin (C17H18Br2N2O) | Actin | Selectively inhibits N-WASP, (member of the Wiskott-Aldrich Syndrome protein (WASp) family) and inhibits activation of Arp2/3 complex. This blocks actin filament assembly. | Soluble in DMSO to 100 mM . Also inhibits PIP2-induced actin polymerization (EC50 ~ 4μM). Inhibits actin-dependent cellular functions (migration, transport, phagocytosis, ruffling). |
Mycalolide B (C52H74N4O17) | Actin | It selectively and completely depolymerizes F-actin to G-actin. Binds to actin in a 1:1 molar ratio (Kd=13-20 nM). | |
Nocodazole (C14H11N3O3S) | Microtubule | Inhibits microtubule dynamics, and promotes tubulin depolymerization. Binds to β-tubulin and prevents the formation of one of the two interchain disulfide linkages. | Soluble in DMSO to 10 mg/ml. Inhibitor of mitosis. Arrests the cell cycle at G2/M phase (prometaphase). Inhibits various cancer-related kinases, including ABL, c-KIT, BRAF, MEK1, MEK2, and MET. |
Vinblastine (C46H58N4O9 · H2SO4) | Microtubule | Depolymerizes microtubules. Binds tubulin and induces self-association in spiral aggregates, inhibiting microtubule assembly. | Soluble in water and methanol. Arrests the cell cycle in G2/M-phase by blocking mitotic spindle formation. Induces apoptosis in several tumor cell lines. Inhibit autophagosome maturation. |
Colchicine (C22H25NO6) | Microtubule | Binds to tubulin and prevents its polymerization | Soluble in ethanol to 50 mg/ml, in water to 100 mM and to 100 mM in DMSO. Inhibitor of mitosis. Induces apoptosis in several normal and tumor cell lines |
Vincristine (C46H56N4O10 · H2SO4) | Microtubule | Indole alkaloid that binds to tubulin and inhibits the formation of microtubules. Depolymerizes microtubules. | Soluble in methanol and water. Delays cell cycle progression. Induces apoptosis in human lymphoma cells. |
Other less commonly used microtubule inhibitors include ciliobrevin D [2], an inhibitor of the minus-end–directed microtubule motor cytoplasmic dynein, and combretastatin A4, an inhibitor of tubulin polymerization [3].
Activators | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Jasplakinolide (C36H45BrN4O6) | Actin | Induces actin polymerization and stabilization in-vitro. Also induces polymerization of actin monomers into F-actin in-vivo. | Soluble in DMSO to >2 mg/ml. A cyclodepsipeptide with fungicidal, insecticidal, and anticancer properties. Non-fluorescent and cell-permeant F-actin. |
Paclitaxel (Taxol) (C47H51NO14) | Microtubule | Binds to the N-terminus of β-tubulin, promotes assembly of microtubules and inhibits tubulin disassembly | Soluble in DMSO and methanol. Antitumor and antileukemic agent Arrests the cell cycle at the G2/M phase. Causes aberrant mitosis and sometimes apoptosis. |
Phalloidin (C35H48N8O11S) | Actin | Binds to polymeric F- actin, stabilizing it and prevents its depolymerization (F-actin to G-actin conversion) | Soluble in ethanol and methanol. Toxic bicyclic heptapeptide isolated from fungi. Interferes with the function of actin-rich structures. Conjugates of phalloidin are used as probes for identifying filamentous actin. |
Endoplasmic reticulum (ER) is an organelle in eukaryotic organisms that forms an interconnected network of membrane vesicles. It is involved in the synthesis, modification, and transport of cellular materials. It extends from the cell membrane through the cytoplasm and connects continuously with the nuclear envelope. The functions of endoplasmic reticulum vary greatly depending on its cell type, cell function, and cell needs. It consists of two regions which differ in both structure and function.
It is a series of flattened sacs and consists of ribosomes on the cytosolic face. Ribosomes are the site of protein synthesis in cells. Rough ER manufactures membranes and secretory proteins, produces antibodies in certain leukocytes, and produces insulin in pancreatic cells. Other functions include initial N-linked glycosylation as assembly continues and manufacture of lysosomal enzymes.
It is a smooth tubule network and does not have ribosomes. It is usually interconnected with rough ER and serves as a transitional area for vesicles that transport ER products to various destinations. It has a wide range of functions which include lipid synthesis, carbohydrate metabolism, calcium concentration, drug detoxification, and attachment of receptors on cell membrane proteins. In muscles smooth ER assists in the contraction of muscle cells, and in brain cells it synthesizes male and female hormones.
An imbalance in the ER mediated protein folding can cause ER stress. The stress signaling pathway or the stress response of endoplasmic reticulum is known as the unfolded protein response (UPR). Initially UPR attempts to restore normal function of the cell by stopping protein translation and activate the signaling pathways that lead to increasing the production of molecular chaperones involved in protein folding. In case UPR fails in its initial attempts and the disruption prolongs, the UPR attempts to induce apoptosis.
Inhibitors mentioned below in Table 3 are used for inhibiting ER functions or induce ER stress, whereas activators mentioned in Table 4 are used to induce ER functions or counteract ER stress.
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Eeyarestatin I (C27H25Cl2N7O7) | Endoplasmic reticulum associated protein degradation (ERAD) | Targets the p97-associated deubiquitinating process (PAD) and inhibits ataxin-3 (atx3)-dependent deubiquitination. Inhibits Sec61-mediated protein translocation at the ER. | Soluble in DMSO to 100mM and in ethanol to 5mM. Induce cytotoxicity in lymphoid cell lines, BJAB, HBL-2, JEKO-1, Jurkat, KMS-12, MINO, as well as primary leukemia cells from CLL. Induces cell death via the proapoptotic protein NOXA. |
DBeQ (C22H20N4) | Endoplasmic reticulum-associated degradation pathway | Inhibits ATPase p97 activity (IC50 = 1.6 µM against WT or C522A p97), in a reversible and ATP-competitive (Ki = 3.2 µM) manner | Soluble in DMSO to 100 mM. Inhibits cell proliferation in RPMI8226, HeLa, and HEK29 cells. Induces caspase 3/7 activity and apoptosis. |
Xestospongin C (C28H50N2O2) | Bradykinin and calcium efflux from ER | Reversibly inhibits bradykinin- and carbamylcholine- Ca2+ efflux from the endoplasmic reticulum stores. | Soluble in DMSO, EtOH, and MeOH. Synthetic form of the macrocyclic bis-1-oxaquinol-izidine. Membrane-permeable. Reversibly inhibits IP3 receptor. |
Kifunensine (C8H12N2O6) | Endoplasmic reticulum associated protein degradation (ERAD) | Inhibits endoplasmic reticulum-associated mannosidase activity. | Soluble in water (double distilled, hot) to 50 mM. Alkaloid compound. Selectively inhibits class I glycoprotein-processing α-mannosidases. |
Tunicamycin (C39H60N4O16) | Protein folding | Induces ER stress. Inhibits N-linked glycosylation and blocks the formation of N-glycosidic protein-carbohydrate linkages. | Soluble in DMF, DMSO and Pyridine. A mixture of Tunicamycins A, B, C and D. Causes G1 arrest. Inhibits GlcNAc phosphotransferase (GPT). Dose-dependent inhibition of DNA synthesis. |
Thapsigargin (C34H50O12) | Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) | Inhibits of sarco-endoplasmic reticulum Ca2+-ATPases. Inhibits the autophagic process, and induces ER stress. | Soluble in DMSO and ethanol. Cell permeable. Induces apoptosis. Used to induce autophagy in mammalian cells. |
ERO1 Inhibitor I, Erodoxin (C7H5BrN2O5) | ER oxidase 1 inhibitor | Selective inhibitor of yeast EndoplasmicReticulum Oxidase 1 (ERO1). Weakly inhibits mouse ERO1α (IC50 = 400 µM) | Soluble in DMSO. inhibits ERO1-dependent oxidation of thioredoxin-1 (Trx1) activity in vitro. Clusters with genes involved in protein folding, glycosylation and cell wall biosynthesis. |
Anti-ER protein 72 (623-638) Rabbit pAb | Recognizes the ~72 kDa ERp72 protein in mouse brain, spleen, testis, and rat brain, muscle, spleen, testis tissue. And human cervical epithelial (HeLa), human fibroblast (A431), human thymus (Hs67), and mouse fibroblast (3T3) cell lysates. |
Activators | Target | Mechanism | Characteristics and effects |
---|---|---|---|
5,8,11-Eicosatriynoic acid (C20H28O2) | Triggers release of Ca2+ from endoplasmic reticulum in MDCK cells. | Causes release of Ca2+ from the endoplasmic reticulum, mitochondria and other stores at 30 µM | Soluble in ethanol to 25mg/ml, in DMSO to 25mg/ml, or dimethyl formamide. Inhibitor of lipoxygenases. Inhibits cyclooxygenases at higher concentrations. |
Salubrinal (C21H17Cl3N4OS) | Protects against ER stress | Protects cells from endoplasmic reticulum stress-induced apoptosis (EC50 ~ 15 μM). | Soluble in DMSO. Selectively inhibits phosphatase complexes that dephosphorylate eukaryotic translation initiation factor 2 subunit α (eIF-2α). |
Tauroursodeoxycholic acid (TUDCA) (C26H44NaNO6S) | Counteracts ER stress | Inhibits endoplasmic reticulum stress. | Soluble in water. Used as detergent for the solubilization of lipids and membrane–bound proteins. |
The Golgi apparatus is an organelle found in eukaryotic cells, and is a part of cell's endomembrane system. The Golgi apparatus is about 1 µM long, and consists of two components: flattened membranous sacs called cisternae and small membrane enclosed vesicles. It plays an important role for processing various proteins before secretion. Table 5 lists commonly used inhibitors of the Golgi apparatus.
The various functions of Golgi include: It receives proteins from protein containing vesicles from the rough endoplasmic reticulum, and further modifies them. It modifies, concentrates, sorts and packages the various macromolecules synthesized by the cell, before secretion or before they are sent to their cellular destinations. It modifies proteins by the addition of carbohydrates and phosphates. It plays a role in synthesizing proteoglycans belonging to the extracellular matrix of animals. Site for synthesis of polysaccharides present in the plant cell wall.
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
1,3-cyclohexanebis methylamine (CBM) ( C6H10(CH2NH2)2 ) | Transport through the Golgi to the plasma membrane. | Inhibits coatomer binding to Golgi membranes in-vitro and in-vivo and secretion by intact cells | Soluble in ethanol and ethyl ether. |
Brefeldin A (BFA) (C16H24O4) | Membrane traffic, Golgi apparatus | Causes disassembly of the Golgi complex and ER swelling in a variety of mammalian cell lines at <40 ng/ml | Soluble in MeOH. Reversibly blocks translocation of proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. Inhibitor of HDL-mediated cholesterol efflux. Mediates apoptosis in human tumor cells. Main constituent of Golgi Plug (for enhancing the detectability of cytokine-producing lymphoid cells with immunofluorescent staining and flow cytometric analysis) |
Golgicide A (C17H14F2N2) | Assembly and transport | Specifically and reversibly inhibits cis-Golgi ArfGEF GBF1, by binding within an interfacial cleft formed between Arf1 and the GBF1 Sec7 domain. Arf belongs to the family of Ras GTPases and mediates vesicular transport. | Soluble in DMSO (>10 mg/ml). Leads to disassembly and dispersal of the Golgi and trans-Golgi network.Inhibits secretion of soluble and membrane associated proteins. |
1-Deoxymannojirimycin (DMM) (C6H13NO4·HCl) | Glycoprotein processing | Inhibits of N-linked glycosylation. Inhibits mannosidase I. | Soluble in ethanol and H2O. Used for studies on Golgi-mediated glycoprotein processing. |
Secretion refers to the production and release of a useful substance by cells or a gland, including hormones, enzymes, cytokines and ECM proteins. The process by which materials are packaged in vesicles, and are secreted from a cell is known as exocytosis. Tables 6 and 7 list commonly used inhibitors and activators of secretion.
In eukaryotic cells, the classical process of secretion occurs through ER, Golgi and other intracellular vesicles, in a highly regulated process. Broadly, proteins targeted for outside dock and translocate through ER, after being synthesized by ribosomes. Vesicles containing the properly folded proteins then enter the Golgi apparatus. After glycosylation and other post-translational modifications, the proteins are moved into secretory vesicles which travel along the cytoskeleton to the edge of the cell. In the last step, exocytosis occurs where the vesicle fuses with cell membrane at a structure called the porosome and the proteins are released in the environment.
There are many proteins that are not secreted through the classical pathway involving ER and Golgi, and instead employ various pathways for secretion. These include FGF-1 (aFGF), FGF-2 (bFGF) and interleukin-1 (IL1) [4, 5]. The mechanisms can be broadly classified as two types. 1) Direct translocation of the substance across plasma membranes of cytoplasmic proteins e.g. FGF2 secretion. 2) Intracellular transport intermediates e.g acyl-CoA binding protein secretion [6].
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
CP-10447 (C16H13BrN2O) | Apolipoprotein B (apoB) secretion | Inhibits microsomal triglyceride transfer protein (MTP, MTTP), and stimulates the early ER degradation of apoB | Soluble in DMSO (≥10 mg/ml). Inhibits triglyceride secretion without affecting triglyceride synthesis. A potent inhibitor of human liver microsomal triglyceride transfer activity. |
Exo 1 (C15H12NFO3) | Exocytosis | Reversibly inhibits vesicular traffic from ER to Golgi in mammalian cells by inducing tubulation and collapsing of the Golgi membrane and redirecting the traffic back to ER | Soluble in DMSO, DMF, MeOH, or EtOH. Its effect is limited to Golgi and does not affect other endocytic organelles. Activates Golgi ARF 1 (ADP-Ribosylation Factor) GTPase . |
Exo 2 (C18H18N4O2S) | Exocytosis | It is similar to BFA, but is more selective. Likely targets include TGN (trans-Golgi network), the Golgi and a subset of early endosomes | Soluble in DMSO (>20 mg/ml). Inhibits the delivery of Shiga toxin to the ER. Acts as a chemical probe of intracellular transport. |
Somatostatin (C76H104N18O19S2) | Growth hormone, insulin, and glucagon | Endogenous peptide that inhibits growth hormone, insulin, and glucagon | Soluble in 5% acetic acid, and 0.30 mg/ml in water. It is a cyclic tetra-decapeptide. Also inhibits voltage-gated Ca2+ channels. |
Octreotide (C49H66N10O10S2) | Gastro-entero-pancreatic peptide hormones and growth hormones | It is a longer acting synthetic octapeptide somatostatin analog | Soluble in H2O. |
SXN101742, a targeted secretion inhibitor (TSI) | Growth hormones | It targets the GHRH (growth hormone-releasing hormone) receptor and depletes a SNARE protein involved in GH (growth hormone) exocytosis. | TSIs are recombinant proteins derived from Botulinum neurotoxins (BoNTs). |
Anti-FGF1 antibody | Acidic fibroblast growth factor (aFGF) | Acidic fibroblast growth factor antibody/Beta-endothelial cell growth factor antibody. Produced in rabbit, or mouse. Reacts with human. Applications include WB, ELISA, IHC-P and Neutralising. Refer to manufacturer's protocol for method and concentration to be used for various applications. |
Activators | Target | Mechanism | Characteristics and effects |
---|---|---|---|
α-Latrotoxin | Induces exocytosis | Binds to latrophilin. Uses both Ca2+ dependent and independent mechanisms. | Soluble in 50% glycerol. Causes neurotransmitter release. Leads to Ca2+-independent insulin exocytosis. Stimulates Ca2+-independent GABA and glutamate release from cortical astrocytes in culture. |
Nateglinide (C19H27NO3) | Insulin | Causes insulin secretion from pancreatic β-cells by increasing cytosolic Ca2+ concentration. | Soluble in DMSO (>5 mg/ml). It is a Kir6.2/SUR1 channel inhibitor. Stimulates both K(ATP) channel-dependent and independent insulin secretion. Hypoglycemic agent. |
Angiotensin II (C50H71N13O12) | Aldosterone | Causes aldosterone release from the adrenal gland | Soluble in H2O or 5% Acetic Acid. Stimulates angiogenesis and increases microvessel density. Has strong vasoconstrictive effects. Activates p60c-src as well as ERK1/2, JNK, and p38 MAP Kinase in vascular smooth muscle cells. |
Tolbutamide (Sulphonylurea) (C12H18N2O3S) | Insulin | Causes insulin release by direct action on the KATP channel of the pancreatic β cells | Soluble in DMSO or 100% ethanol Metabolized by CYP2C9 (tolbutamide hydroxylase). |
Repaglinide (C27H36N2O4) | Insulin | Closes ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell | Soluble to 100 mM in DMSO and to 100 mM in ethanol. Has hypoglycaemic effect in-vivo. |
Sodium oleate (CH3(CH2)7CH=CH(CH2)7COONa) | Apolipoprotein B100 (Apo-B) | Increases hepatic secretion of apolipoprotein B100 | Soluble in water (100 mg/ml), methanol (50 mg/ml), and ethanol. Activates Protein Kinase C (PKC) in hepatocytes. Inhibits apolipoprotein B100 secretion at higher physiologic doses. |
Secretin (C130H220N44O40) | Pancreatic fluid | Stimulates secretion of carbonate-rich pancreatic fluid | Soluble in 5% Acetic Acid or H2O. It is a strongly basic gastrointestinal peptide hormone. Relaxes smooth muscle. Causes a dose-dependent increase in cAMP accumulation in pancreatic duct lines. |
Nuclear transport mainly occurs via the nuclear pore complexes (NPCs). Ions and small molecules are transported by passive diffusion through the NPCs. The import of larger nuclear proteins, RNAs, and ribonucleoproteins is mediated by nuclear localization signals (NLS) which mediate the docking at the nuclear pore. On the other hand, nuclear export is mediated by nuclear export signals (NES).
Nuclear import pathway broadly consists of four steps: 1) trimeric complex formation between the import substrate, importin α and importin β, 2) docking of the complex to NPC (Nuclear Pore Complexes), 3) translocation through the central channel, 4) dissociation of the complex and the release of the import substrate into the nucleoplasm. Table 8 lists commonly used inhibitors of nuclear transport.
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Wheat germ agglutinin (WGA) | Nuclear import | Inhibits nuclear protein transport by interacting directly with the nuclear pore. | A widely used lectin in cell biology. Has an affinity for N-acetyl-β-D-glucosaminyl residues and N-acetyl-β-D-glucosamine oligomers. Used in cell adhesion studies. Also used to effect lymphocyte activation, and to study carbohydrate-based therapeutics. |
Leptomycin A (C32H46O6) | Nuclear export | Direct binds of to CRM1 (Exportin-1), which is the main nuclear export protein. | Soluble in methanol and ethanol. Properties of Leptomycin A and B are similar. Cell-permeable antifungal antibiotic. Can induce, nuclear accumulation of wild-type ERK5. |
Leptomycin B (C33H48O6) | Nuclear export | Inhibits nuclear transport-receptor Crm1, which is required to recognize short peptides in substrate proteins called nuclear export sequences (NES) | Soluble in ethanol. Anti-fungal antibiotic. Anti-tumor cytotoxin. Twice as potent as Leptomycin A. NES containing proteins affected by Leptomycin B include HIV-1 REV; actin, c-Abl, cyclin B1, MDM2/p53, MPF, PKA and MEK. |
Ratjadone A (C28H40O5) | Nuclear export | Inhibits nuclear export of LR-NES (leucine rich - nuclear export signal)-containing proteins by covalently binding to CRM1 | Soluble in aqueous buffers and methanol. A cell-permeable polyketide. Antibiotic. As potent as leptomycin B. Inhibits proliferation. Causes cell cycle arrest of tumor cells at G1 phase. |
Ivermectin (C48H74O14 (22,23-dihydroavermectin B1a) + C47H72O14 (22,23dihydroavermectin B1b) | Nuclear import | Recently identified as a broad spectrum of importin α/β-mediated nuclear import | Antiviral. Useful for studying protein nuclear import. Modulates glutamate-GABA-activated chloride channels. |
Commonly peptides designed as NLS are conjugated to import substrate, to induce nuclear import. On the other hand, cell-permeable-peptides designed specific to nuclear transport receptors such as importins and transportins, which recognise NLS, are used for inhibiting nuclear transport [7].
Phospholipase C (PLC), Protein Kinase C (PKC), Rho GTPase, Rho kinase (downstream effector of RhoA), myosin light chain kinase (MLCK), and myosin light chain phosphatase (MLCPh) participate in the process of cell contraction at a particular intracellular Ca2+ concentration.
Role of MLCK and MLCPh: Actin and myosin interactions are primarily responsible for mediating cell contraction. Phosphorylation of myosin light chain initiates the molecular interaction between actin and myosin. This phosphorylation of myosin light chain is determined by the balance between myosin light chain kinase (MLCK) activation and myosin light chain phosphatase (MLCPh).
Role of Rho GTPase and Rho-Kinase: Rho GTPase is activated in response to cell and microenvironment interactions through adhesion sites. Activated Rho GTPase binds to kinases such as serine/threonine kinases, Rho Kinase, ROK and the related p160ROCK; and elevate their activity. Activated Rho-Kinase inhibits myosin phosphatase activity leading to an increase in phosphorylated myosin light chain (MLC).
Role of PLC, Ca2+and PKC [8] : The process of contraction starts with activation of phospholipase C (PLC), which results in the production two second messengers namely diacylglycerol (DG) and inositol 1,4,5-trisphospate (IP3). IP3 causes the release of Ca2+ from the sarcoplasmic reticulum. Ca2+ can induce contraction in two ways: 1) Ca2+ along with DG activates protein kinase C. PKC further promotes contraction by phosphorylation of L-type Ca2+ channels and other proteins that regulate cross-bridge cycling, 2) Ca2+ binds to calmodulin and causes activation of myosin light chain kinase (MLCK).
Inhibitors and activators used to study cell contractility pathway are listed in Table 9 and Table 10.
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Staurosporine (C28H26N4O3) | Myosin light chain kinase (MLCK), Protein Kinase C (PKC) | Inhibits, myosin light chain kinase (IC50 = 1.3 nM), protein kinase C (IC50 = 700 pM) | Soluble in DMSO and MeOH. Also inhibits protein kinase A (IC50 = 7 nM), and protein kinase G (IC50 = 8.5 nM). Arrests cell cycle at the G1 checkpoint in normal cells. |
Y-27632 (C14H21N3O · 2HCl) | ROCK | Reversible and selective inhibitor of Rho-associated protein kinases (Ki = 140 nM for p160ROCK). Also inhibits ROCK-II. The inhibition is competitive with respect to ATP. | Soluble in H2O at 14 mg/ml. Inhibits agonist-induced Ca2+ sensitization of myosin phosphorylation and smooth muscle contraction. Also inhibits the protein kinase C-related protein kinase, PRK2 (IC50 = 600 nM) . Has also been shown to prevent apoptosis and enhance the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency. |
H-1152 (C16H21N3O2S.2HCl) | ROCK | Selective ATP -competitive inhibitor of rho-kinase (ROCK) | Soluble to 100 mM in water and to 50 mM in DMSO. More potent and selective than Y-27632. Exhibits weaker affinity for other serine/threonine kinases (Ki=630nM for PKA, 9.27mM for PKC and 10.1mM for MLCK). |
ML-9 (C15H17N2O2SCl · HCl) | Myosin light chain kinase (MLCK), Protein Kinase C (PKC) | Selective inhibitor of myosin light chain kinase (MLCK) (Ki = 4 μM) and PKC (Ki = 54 μM) | Soluble to 25 mM in DMSO. Inhibits. PKA (Ki = 32 μM). Inhibits vascular smooth muscle tension and reduces intracellular Ca2+ concentrations when used at a concentrations from 10-100 µM. |
ML-7 (C15H17IN2O2S · HCl) | Myosin light chain kinase (MLCK) | ATP-competitive and selective inhibitor of myosin light chain kinase (Ki = 300 nM) | Soluble in DMSO or 50% EtOH. Inhibits protein kinase A (Ki = 21 µM) and protein kinase C (Ki = 42 µM) at higher concentrations. Derivative of ML-9. More potent inhibitor as compared to ML-9. |
K-252a (C27H21N3O5) | MLCK, PKC | Inhibits PKC (IC50 = 32.9 nM) and MLCK (Ki = 20 nM). Also inhibits PKA, PKG, CaMK, phosphorylase kinase, MAP kinase, and the trk family of receptor tyrosine kinases by acting as a competitive inhibitor with respect to ATP. | Soluble in DMF or DMSO. Analog of staurosporine. Prevents auto-phosphorylation and activation of downstream effectors (MAPK, Akt). Causes apoptosis and cell cycle arrest by inhibiting Cdc2 and Cdc25. |
Trifluoperazine | Calmodulin | Calmodulin antagonist. Inhibits Ca2+/calmodulin-dependent phosphodiesterase. | Phenothiazine antipsychotic D2 dopamine receptor antagonist, inhibits cAMP-gated cationic channels (IC50 = 13 µM), and inhibits hepatic ornithine decarboxylase activity. |
W-7 ( C16H21ClN2O2S · HCl) | Calmodulin | Inhibits Ca2+/calmodulin activated phosphodiesterase (IC50 = 28 µM) and myosin light chain kinase (IC50 = 51 µM). | Inhibits proliferation of hamster ovary K1 cells. |
Activators | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Endothelin I (C109H159N25O32S5) | MLC phosphorylation | Potent vasoconstrictor. Endothelin I mediates contraction through activation of Rho Kinase pathway and subsequent MLC phosphorylation | Soluble in 1% acetic acid and water to >1mg/ml. Induces production of hypoxia-inducible factor 1α, and the production of VEGF. Activates PLC in fibroblasts expressing ETA receptors. |
Calpeptin (C20H30N2O4) | Rho GTPase | Activates RhoA, B and C. RhoA activation is possibly because of inhibition of myosin light chain phosphorylation | Soluble in DMSO and DMF. It is an inhibitor of calpain which is a Ca2+-dependent protease, potent inhibitor of cathepsin L and preferentially inhibits membrane-associated tyrosine phosphatase activity. |
Phorbol 12-myristate 13-acetate (PMA) (C36H56O8) | Protein Kinase C | Reversibly binds to PKC | Photosensitive. DMSO & ethanol soluble. Activates PKC even at nM concentrations in-vitro and in-vivo. It is also a potent tumor promoter. |
Mezerein (C38H38O10) | Protein Kinase C | Activates protein kinase C at nM concentrations. | 100% solubility in ethanol. Tumor promoter. Induces interleukin-1α, and is a co-inducer of interferon with phytohemagglutinin. |
BAY K 8644 (C16H15F3N2O4) | Ca2+ channel | L-type Ca2+-channel activator (EC50 = 17.3 nM) | Soluble in methanol (63 mg/ml), ethanol (63 mg/ml) and DMSO (20 mg/ml). Inhibits autophagy. Promotes β-cell proliferation and regeneration. |
Phorbol-12,13-dibutyrate (PDBu) (C28H40O8) | Protein Kinase C | Activates protein kinase C | Photosensitive. Soluble in H2O, DMSO, acetone, ethanol. Easier to wash out of cells in tissue culture than PMA, as comparatively less hydrophobic. It causes phosphorylation of Na+,K+- ATPase. It also promotes nitric oxide production. |
Table 11 and Table 12 list commonly used inhibitors and activators of cell adhesion and cell junctions.
Cells use cell adhesion molecules to interact and adhere to a surface such as an extracellular matrix, other cells, or cell culture surface. Cell adhesion molecules (CAMs) include selectins, integrins and cadherins. Each type of adhesion molecule recognizes different molecules and has varied functions. Selectins are single chain transmembrane glycoproteins that bind to sugar moieties. There are 3 types of selectins namely L-, E-, and P-selectin [9-12]. Another important group is the Immunoglobulin Superfamily (IgSF CAMs). This family includes NCAMs (Neural Cell Adhesion Molecules), ICAM-1 (Intercellular Cell Adhesion Molecule), VCAM-1 (Vascular Cell Adhesion Molecule), and PECAM-1 (Platelet-endothelial Cell Adhesion Molecule).

Cell-cell adhesions are mainly mediated by cadherins, a class of type-1 transmembrane proteins that are dependent on calcium ions for their function. They are a superfamily of cell adhesion molecules (CAMs) and are divided into subclasses, including E-, N- and P-cadherins [13-16].
Cell adhesion to ECM (extra cellular matrix) is mainly mediated by integrins. Integrins are a family of heterodimeric transmembrane glycoproteins. They are formed of large 'α' subunits of sized 120-170 kDa and small 'β' units of sizes 90-100 kDa. A variety of integrins are formed from 9 types of β subunits and 24 types of α subunits [17-20].
There are several types of cell junctions as discussed below. Synapses and neuromuscular junctions, part of the nervous systems, are to be considered as types of cell junction; they are not discussed here.
They include adherens junctions, desmosomes, and hemidesmosomes. Adheren junctions are observed in many cell types and are common in epithelial cells. The cytoplasmic face of the cell junction is liked to actin cytoskeleton. Here cadherin receptors bridge the neighboring plasma membranes via their homophilic interactions. Desmosomes are specialized for cell-cell adhesion, and are common in cells derived from the ectodermal lineages. They help cells in resisting mechanical stress. They are required in the epithelium, binding cells in muscle tissues, and maintaining the integrity of organs such as the skin and heart [21, 22]. Hemidesmosomes are similar in form to desmosomes. Unlike desmosomes which bind two cells together, hemidesmosomes bind one cell to the extracellular matrix.
They are composed of arrays of small channels where each channel is composed of two connexons, and directly link the cytoplasm of two cells. They facilitate the transport of various molecules and ions between two cells, thereby mediating electrical and mechanical coupling.
Also known as occluding junctions, seal the gap between two cells by forming an impermeable barrier. They directly link the cytoskeleton of two cells.
Inhibitors | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Echistatin (α1 isoform) (C217H341N71O74S9) | Cell adhesion to ECM | Integrin β1 and β3 | Soluble to 1 mg/ml in water. Member of the disintegrin family. Disrupts attachment of osteoclasts to bone . Inhibits adhesion of melanoma cells and fibroblasts to fibronectin. Inhibits platelet aggregation. |
Poly(2-hydroxyethyl methacrylate) (C6H10O3)n | Cell adhesion to tissue culture treated surfaces. | Inhibit cell adhesion to growth surfaces in culture vessels | Soluble in ethanol. Water-swellable polymer. |
CyloRGDfV (C26H38N8O7) Or RGDS peptide | Cell binding to RGD | It is an RGD-containing peptide antagonist. It is specific for α(V)β(3) integrin. | It is used to inhibit the binding of cells to RGD proteins such as vitronectin and fibronectin. |
KF 38789 (C19H21NO5S) | P-selectin-mediated cell adhesion | Specifically inhibits of P-selectin-mediated cell adhesion (IC50 = 1.97 μM). | Soluble in DMSO to 100 mM. |
A 205804 (C15H12N2OS2) | Cell-cell adhesion (E-selectin, ICAM-1) | Specifically inhibits of E-selectin and ICAM-1 expression. | Soluble in DMSO to 100 mM and in ethanol to 10 mM. |
A 286982 (C24H27N3O4S) | Cell-cell adhesion (LFA-1 - ICAM-1) | Inhibits LFA-1/ICAM-1 interaction. | Soluble to 100 mM in DMSO and to 50 mM in ethanol. |
FAK Inhibitor 14 (1,2,4,5-benzenetetraamine tetrahydrochloride) (C6H10N4.4HCl) | Cell adhesion (focal adhesion kinase) | Specifically inhibits focal adhesion kinase (FAK). Inhibits cell adhesion in vitro | Soluble in water and in DMSO. |
PF 573228 (C22H20F3N5O3S) | Cell adhesion (focal adhesion kinase) | Specifically inhibits focal adhesion kinase (FAK) (IC50 = 4 nM). | Soluble in DMSO. Interrupts serum and fibronectin-directed migration. Non-receptor tyrosine kinase inhibitor. |
Obtustatin (C184H284N52O57S8) | Cell adhesion (α1β1 inhibitor) | 41 amino acid disintegrin peptide, which is highly potent integrin α1β1 inhibitor | Soluble in water to 2 mg/ml. Inhibits angiogenesis in vivo. Does not contain the classical RGD sequence. |
Lebestatin | Integrin-mediated cell adhesion | Member of disintegrin family. | |
Eptifibatide (C35H49N11O9S2) | Glycoprotein IIa/IIIb | Inhibits platelet receptor integrin glycoprotein IIb/IIIa | Soluble in water. Inhibits platelet aggregation. |
Activators | Target | Mechanism | Characteristics and effects |
---|---|---|---|
Peptide F9 (C110H175N31O27S2) | Cell adhesion | Binds to Heparin. | Soluble in water. It is a peptide derived from the heparin-binding domain in the B1 chain of laminin. |
RGD peptide | Cell adhesion | Binds to integrins | Used to guide integrin mediated cell adhesion to biomaterials, polymers and nanoparticles. |
Frottin F et al treated HEK293T cells with 100 ng/ml of the RNA polymerase I inhibitor actinomycin D from MilliporeSigma to induce nucleolar disassembly in order to study nucleolus as a phase-separated protein quality control entity [23].
Labome surveys literature for the applications for antibodies and other reagents, and instruments. Table 13 lists activators and inhibitors cited in these articles, and their main suppliers.
area | chemical | supplier | num | reference |
---|---|---|---|---|
Cell Cytoskeleton | Cytochalasin B | |||
MilliporeSigma | 6 | [2] | ||
Cytochalasin D | ||||
MilliporeSigma | 5 | [24] | ||
Santa Cruz Biotechnology | 1 | [25] | ||
Tocris | 1 | [26] | ||
FUJIFILM Wako Chemical | 1 | [27] | ||
Latrunculin A | ||||
MilliporeSigma | 3 | [24] | ||
Santa Cruz Biotechnology | 1 | [25] | ||
Abcam | 1 | [2] | ||
Latrunculin B | ||||
BioMol/Enzo | 2 | [26] | ||
MilliporeSigma | 2 | [28] | ||
Nocodazole | ||||
MilliporeSigma | 19 | [29, 30] | ||
Thermo Fisher | 1 | [31] | ||
Paclitaxel | ||||
Cytoskeleton | 3 | [32] | ||
MilliporeSigma | 6 | [33] | ||
Teva | 1 | [34] | ||
Thermo Fisher | 1 | [24] | ||
Phalloidin | ||||
Thermo Fisher | 37 | [35] | ||
MilliporeSigma | 8 | [36] | ||
Vincristine | ||||
MilliporeSigma | 1 | [37] | ||
Endoplasmic Reticulum | Kifunensine | |||
Toronto Research Chemicals | 1 | [38] | ||
Thapsigargin | ||||
MilliporeSigma | 13 | [39] | ||
Tunicamycin | ||||
Cayman Chemicals | 1 | [40] | ||
MilliporeSigma | 8 | [41] | ||
Xestospongin C | ||||
Abcam | 1 | [42] | ||
Golgi | Brefeldin A | |||
MilliporeSigma | 19 | [39, 43] | ||
Golgicide A | ||||
MilliporeSigma | 1 | [44] | ||
Endocytosis | methyl-β-Cyclodextrin | |||
MilliporeSigma | 6 | [45] | ||
Filipin | ||||
MilliporeSigma | 4 | [46] | ||
Nystatin | ||||
MilliporeSigma | 3 | [45] | ||
Monensin | ||||
BD Biosciences | 1 | [47] | ||
eBioscience | 1 | [48] | ||
MilliporeSigma | 2 | [49] | ||
Chloroquin | ||||
MilliporeSigma | 6 | [50] | ||
Wortmannin | ||||
Cell Signaling Technology | 1 | [51] | ||
MilliporeSigma | 8 | [52] | ||
Phorbol ester (PMA/TPA) | ||||
AppliChem | 1 | [53] | ||
Enzo | 1 | [54] | ||
MilliporeSigma | 35 | [44] | ||
Cell Contraction | staurosporine | |||
MilliporeSigma | 5 | [55] |
- Prudovsky I, Mandinova A, Soldi R, Bagala C, Graziani I, Landriscina M, et al. The non-classical export routes: FGF1 and IL-1alpha point the way. J Cell Sci. 2003;116:4871-81 pubmed
- Webb R. Smooth muscle contraction and relaxation. Adv Physiol Educ. 2003;27:201-6 pubmed
- Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9:263-8 pubmed
- Rosen S, Bertozzi C. The selectins and their ligands. Curr Opin Cell Biol. 1994;6:663-73 pubmed
- Cummings R, Smith D. The selectin family of carbohydrate-binding proteins: structure and importance of carbohydrate ligands for cell adhesion. Bioessays. 1992;14:849-56 pubmed
- McEver R. Selectins. Curr Opin Immunol. 1994;6:75-84 pubmed
- Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988;102:639-55 pubmed
- Halbleib J, Nelson W. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006;20:3199-214 pubmed
- Angst B, Marcozzi C, Magee A. The cadherin superfamily: diversity in form and function. J Cell Sci. 2001;114:629-41 pubmed
- Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8:215 pubmed
- Berman A, Kozlova N, Morozevich G. Integrins: structure and signaling. Biochemistry (Mosc). 2003;68:1284-99 pubmed
- Humphries J, Byron A, Humphries M. Integrin ligands at a glance. J Cell Sci. 2006;119:3901-3 pubmed
- Qin J, Vinogradova O, Plow E. Integrin bidirectional signaling: a molecular view. PLoS Biol. 2004;2:e169 pubmed
- Schmidt A, Koch P. Desmosomes: just cell adhesion or is there more?. Cell Adh Migr. 2007;1:28-32 pubmed
- Green K, Jones J. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 1996;10:871-81 pubmed
- Materials and Methods [ISSN : 2329-5139] is a unique online journal with regularly updated review articles on laboratory materials and methods. If you are interested in contributing a manuscript or suggesting a topic, please leave us feedback.
- method
- 3D Cell Culture: A Review
- Antibody Quality
- Cell Culture Media: A Review
- Cell Lines Companies
- Cell Markers
- Cell Signaling Technology Antibodies
- Endocytosis
- Flow Cytometry and Cell Sorting: A Practical Guide
- Incorporating Unnatural Amino Acids into Recombinant Proteins in Living Cells
- Live Cell Imaging
- Neuronal Cell Markers
- Organelle Markers
- Stem Cell Markers
- Stem Cell Research Using Mouse Models
- Stem Cells
- Subcellular Fractionation
- The Cell Cycle Analysis
- siRNAs and shRNAs: Tools for Protein Knockdown by Gene Silencing